Icon

TRILEPTAL (nda021014)- (150MG,300MG,600MG)

OXCARBAZEPINE NOVARTIS
150MG,300MG,600MG
Yes No
2018-Aug-12 Expired
None None
None No
TRILEPTAL is indicated for:  Adults: Monotherapy or adjunctive therapy in the treatment of partial-onset seizures  Pediatrics: - Monotherapy in the treatment of partial-onset seizures in children 4–16 years - Adjunctive therapy in the treatment of partial-onset seizures in children 2–16 years.
9 0 6
Total Other Developers 5
Drugs with Suitability No
150MG ** ** - - 5
300MG ** ** Up - 5
600MG ** ** Up - 5
NDA Sales Available Total Generic Sales Available
Yes 5
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******* ******* ******** ******* ******* *********** **** ** *-**/* & ***/*, ****, ********** ********* ****,, *****, *********** *** ***, ***** (***) ***
****** *** ***** **** *** ************** ********** ******* *********** *****-****** *******, *****, ******* ******, ***** (***) ***
****** **** **** ************** ********** ***. *********** ** ******* ******, ***** ***, *******, ****** (***) ***
****** ******** ****** *** ******** *************** ******* *********** **** **. *, *****-*, ****** **** *** *********, ****, ****** ******* ******, ***** (***) ***
****** ******** ****** *** ******** *************** ******* *********** **** ** *-*, ******* ********** ******, *******-******,, ***, ** ******, ***** (***) ***
****** ************ ***** *** ****** *********, *** *********** ***** ******** ******, ******, ********** (**) *****, ****** ****** (***) ***
****** ************ ***** **** ************** ******, *.*. *********** ***** ** **** *****, **-**, ***********, *****, ***** (***) ***
****** ****** ****** ****** ****** ******* ******* *********** ****** **. ***, ******* *******, *********** ******,, **********, ********* ******, ***** (***) ***
****** ****** ****** ****** *************** *** *********** *** ******** **, *********, *** **** (**) *****, ****** ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.